Skip to main content
SpringerLink
Log in
Book cover

Liver-Directed Therapy for Primary and Metastatic Liver Tumors pp 77–99Cite as

Indications and Results of Liver Transplantation for Primary and Metastatic Liver Cancer

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 109))

Abstract

Orthotopic liver transplantation (OLT) has become an established treatment for end-stage liver disease (ESLD), acute liver failure, and malignant tumors. Transplantation for hepatic malignancies is indicated in the setting of either unresectible lesion(s), or coexistent cirrhosis resulting in both inadequate hepatic reserve and prohibitive portal hypertension.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 321:1014–1022, 1092–1099, 1989.

    Article  PubMed  CAS  Google Scholar 

  2. Klintmalm GB, Stone MJ. Liver transplantation for malignancy. Transplant Rev 4:52–8, 1990.

    Article  Google Scholar 

  3. Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc 20(suppl) l):478–82, 1988.

    PubMed  CAS  Google Scholar 

  4. Olthoff KM, Millis JM, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125:1261–8, 1990

    Article  PubMed  CAS  Google Scholar 

  5. O’Grady JG, Poison RJ, Rolles K, et al. Liver transplantation for malignant disease. Ann Surg 207:373–9, 1988

    Article  PubMed  Google Scholar 

  6. Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 202:401–7, 1985

    Article  PubMed  CAS  Google Scholar 

  7. Pichlmayr R, Ringe B, Bechstein WO, et al. Approach to primary liver cancer. Recent Results Cancer Research 110:65–73, 1988

    Article  CAS  Google Scholar 

  8. Ringe B, Wittekind C, Bechstein, WO, et al. The role of liver transplantation in hepatobiliary malignancy. Ann Surg 209:88–98, 1989

    Article  PubMed  CAS  Google Scholar 

  9. Perm I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 110:726–35, 1991

    Google Scholar 

  10. Carr BI, Kar S. An assay for hepatoma micrometastases: albumin gene expression in peripheral blood from patients with advanced hepatocellular carcinoma (HCC) (abstr). Hepatology 14:108A, 1991

    Google Scholar 

  11. Neuhaus P, Broelsch CE, Ringe B, Pichlmayr R. Liver transplantation for liver tumors. Recent Results Cancer Research. 100:221–8, 1986.

    Article  CAS  Google Scholar 

  12. Koneru B, Cassaville A, Bowman J, et al. Liver transplantation for malignant tumors. Gastroenterology Clin North Amer 17:177–93, 1988.

    CAS  Google Scholar 

  13. Jenkins RL, Pinson CW, Stone MD. Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 23(Suppl):S 104–9, 1989.

    Article  Google Scholar 

  14. Pichlmayr R. Indications for liver grafting in hepatic tumors. In Bannasch P, Keppler D, Weber G, eds. Liver Cell Carcinoma. Boston, Kluwer Academic, 1989, pp 491–7.

    Google Scholar 

  15. Flye MW, McCullough CS. Liver transplantation for malignant disease. Principles Pract Oncol 3:1–12,1989.

    Google Scholar 

  16. Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188–93, 1990.

    PubMed  CAS  Google Scholar 

  17. Ismail T, Angrisani I, Gunson B, et al, Primary hepatic malignancy: the role of liver transplantation. Br JSWg 77:983–7, 1990.

    Article  CAS  Google Scholar 

  18. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15:270–85, 1991.

    Article  PubMed  CAS  Google Scholar 

  19. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214:221–9, 1991.

    Article  PubMed  CAS  Google Scholar 

  20. Stevens L, Piper J, Emond J, et al. Liver transplantation for controversial indications: alcoholic liver disease, hepatic cancers, and viral hepatitis. Transplant Proc 23:1915–6, 1991.

    PubMed  CAS  Google Scholar 

  21. Van Thiel DH, Carr B, Iwatsuki S, et al. Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc 23:1917–21,1991.

    PubMed  Google Scholar 

  22. Van Thiel DH, Carr BI, Yokoyama I, et al. Liver transplantation as a treatment of hepatocellular carcinoma. In Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston, TX, Gulf, 1991, pp 309–15.

    Google Scholar 

  23. Haug CE, Jenkins RL, Rohrer RJ, et al. Liver transplantation for primary hepatic cancer. Transplantation 53:376–82, 1992.

    Article  PubMed  CAS  Google Scholar 

  24. Ellis LM, Demers MI, Roh MS. Current strategies for the treatment of hepatocellular carcinoma. Curr Opin Oncol 4:741–51, 1992.

    Article  PubMed  CAS  Google Scholar 

  25. Stone MJ, Klintmalm G, Polter D, et al. Neoadjuvant chemotherapy and orthotopic liver transplantation for hepatocellular carcinoma. Transplantation 48:344–7, 1989.

    Article  PubMed  CAS  Google Scholar 

  26. Stone MI, Klintmalm GBG, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 104:196–202, 1993.

    PubMed  CAS  Google Scholar 

  27. Ahlgren JD.Neoplasms of the hepatobiliary system. In Calbresi P, Schein PS, eds. Medical Oncology. New York, McGraw-Hill, 1993, pp, 713–39.

    Google Scholar 

  28. Craig JR, Peters RJ, Edmondson HA. Tumors of the Liver and Intrahepatic Bile Ducts. Washington, DC: Armed Forces Institute of Pathology, 1989.

    Google Scholar 

  29. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N EnglJ Med 340:745–50, 1999.

    Article  CAS  Google Scholar 

  30. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular-cholangiocarcinoma. Cancer 55:124–35, 1985.

    Article  PubMed  CAS  Google Scholar 

  31. McPeake J, and Williams R. Liver transplantation for malignancy: the current position. In Terblanche J, ed. Hepatobiliary Malignancy, It’s Multidisciplinary Management, Edward Arnold, London, 1994, pp 595–618.

    Google Scholar 

  32. Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 155: 49–54, 1990.

    Article  CAS  Google Scholar 

  33. Dodd GD, Miller WJ, Baron RL, Skolnick ML, Campbell WL. Detection of malignant tumours in end-stage cirrhotic livers: efficacy of sonography as a screening technique. Am J Roentgenol 159: 727–33, 1992.

    Article  Google Scholar 

  34. Miller WJ, Federle MP, Campbell WL. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients. Amer J Roentgenol 157:303–6, 1991.

    Article  CAS  Google Scholar 

  35. Parker G A, Lawrence W, Horsley S, et al. Intraoperative ultrasound of the liver affects operative decision making. Ann Surg 209:569–77, 1989.

    Article  PubMed  CAS  Google Scholar 

  36. Kudo M. Imaging Diagnosis of Hepatocellular Carcinoma. Seminars in Liver Disease 19;297–310, 1999.

    Article  PubMed  CAS  Google Scholar 

  37. Tsunetomi S, Ohto M, lino Y, et al. Diagnosis of small hepatocellular carcinoma by computed tomography: correlation of CT findings and histopathology. J Gastroenterol Hepatol 4:395–404, 1989.

    Article  PubMed  CAS  Google Scholar 

  38. Sitzmann JV, Coleman J, Pitt HA, et al. Preoperative assessment of malignant hepatic tumors. Am Surg 159:137–43, 1990.

    Article  CAS  Google Scholar 

  39. Rummeny E, Weissleder R, Stark DD, et al. Primary liver tumors: diagnosis by MR imaging. Am J Roentgenol 159:137–43, 1989.

    Google Scholar 

  40. Muramatsu Y, Nawano S, Takayasu K, et al. Early hepatocellular carcinoma: MR imaging. Radiology 181:209–13, 1991.

    PubMed  CAS  Google Scholar 

  41. Cohen MB, Haber MM, Holly EA, et al. Cytologic criteria to distinguish hepatocellular carcinoma from normoplastic liver. Am J Clin Pathol 95:125–30, 1991.

    PubMed  CAS  Google Scholar 

  42. Beahrs OH, Henson DE, Hutter RVP, Kennedy W, eds. Manual for Staging of Cancer. Philadelphia, JB Lippincott, 1992, pp 89–91.

    Google Scholar 

  43. Foster JH. Evaluation of asymptomatic solitary hepatic lesions. Ann Rev Med 39:85–93, 1988.

    Article  PubMed  CAS  Google Scholar 

  44. Rummeny E, Weissleder IT, Stark DD, et al. Primary liver tumors: diagnosis by MR imaging. Am J Roentgenol 152:63–72, 1989.

    Article  CAS  Google Scholar 

  45. Ferrucci JT. Liver tumor imaging. Cancer 67:1189–95, 1991.

    Article  PubMed  CAS  Google Scholar 

  46. Miller WJ, Federle MP, Campbell WL. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients. Am J Roentgenol 157:303–6, 1991

    Article  CAS  Google Scholar 

  47. Johnson CD. Magnetic resonance imaging of the liver, current clinical applications. Mayo Clin Proc 68:147–56, 1993.

    Article  PubMed  CAS  Google Scholar 

  48. Edelman RR, Warach S. Magnetic resonance imaging. N Engl J Med 328:708–16,785–91, 1993.

    Google Scholar 

  49. Calne RY, Williams R, Rolles K. Liver transplantation in the adult. World J SVg 10: 422–31, 1986.

    Article  CAS  Google Scholar 

  50. Krom RA, Gips CH, Houthoff HJ, et al. Orthotopic liver transplantation in Groningen, The Netherlands (1979–1983). Hepatology 4(suppl):61S-65S, 1984.

    Article  Google Scholar 

  51. Di Bisceglie AM, Rustgi VY, Hoofhagle JH, et al. Hepatocellular carcinoma. Ann Intern Med 108:390–401, 1988.

    PubMed  Google Scholar 

  52. Ahlgren JD, Wanebo HJ, Hill MC. Hepatocellular carcinoma. In Ahlgren JD, Macdonald JS, eds. Gastrointestinal Oncology. Philadelphia, JB Lippincott, 1992, pp 417–36.

    Google Scholar 

  53. Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 15:1–31, 1988.

    Article  PubMed  CAS  Google Scholar 

  54. Falkson G, Cnaan A, Schutt AJ, et al. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 48:7314–8, 1988.

    PubMed  CAS  Google Scholar 

  55. Falkson G. Treatment for patients with hepatocellular carcinoma: state-of-the-art. Ann Oncol 3:336–7, 1992.

    PubMed  CAS  Google Scholar 

  56. Taketa K. a-fetoprotein: réévaluation in hepatology. Hepatology 12:1420–32, 1990.

    Article  PubMed  CAS  Google Scholar 

  57. Epstein B, Ettinger D, Leichner P, Order SE. Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma. Cancer 67:896–900, 1991.

    Article  PubMed  CAS  Google Scholar 

  58. Beasley RP. Hepatitis B virus. Cancer 61:1942–56, 1988.

    Article  PubMed  CAS  Google Scholar 

  59. Wands JR, Blum HE. Primary hepatocellular carcinoma. N Engl J Med 325:729–31, 1991.

    Article  PubMed  CAS  Google Scholar 

  60. de Franchis IT, Meucci G, Vecchi M, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118:191–4, 1993.

    PubMed  Google Scholar 

  61. Simonetti RG, Cammi C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 116:97–103, 1992.

    PubMed  CAS  Google Scholar 

  62. Tabor E, Kobayashi K. Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis: prevalence and structure-Summary of a conference on hepatitis C virus as a cause of hepatocellular carcinoma. J Natl Cancer Inst 84:86–90, 1992.

    Article  PubMed  CAS  Google Scholar 

  63. Tsukama H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797–1801, 1993.

    Article  Google Scholar 

  64. Wogan GN. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 52(Suppl):2114–8S, 1992.

    Google Scholar 

  65. Deugnier YK Guyader D, Crantock L, et al. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 104:228–34, 1993.

    PubMed  Google Scholar 

  66. Iwatsuki S, Starzl TE. Personal experience with 411 hepatic resections. Ann SWg 208:421–434, 1988.

    CAS  Google Scholar 

  67. Theise ND, Schwartz M, Miller C, Thung SN. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver expiants with cirrhosis. Hepatology 16:949–55, 1993.

    Article  Google Scholar 

  68. Olthoff KM, Millis JM, Rosove MH, Goldstein LI, Ramming KP, Busuttil RW. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125:1261–6, 1990.

    Article  PubMed  CAS  Google Scholar 

  69. Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 209:88–98, 1989.

    Article  PubMed  CAS  Google Scholar 

  70. Iwatsuki S, Gordon RD, Shaw BJ, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 202:401–7, 1985.

    Article  PubMed  CAS  Google Scholar 

  71. Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188–93, 1990.

    PubMed  CAS  Google Scholar 

  72. Yokoyama I, Sheahan DG, Carr B, et al. Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 23:2194–6, 1991.

    PubMed  CAS  Google Scholar 

  73. McPeake JR, O’Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determines outcome. J Hepatol 18:226–34, 1993.

    Article  PubMed  CAS  Google Scholar 

  74. Pichlmayr R, Ringe B, Wittekind C, et al. Liver grafting for malignant liver tumors. Transplant Proc 21:2403–5, 1989.

    Google Scholar 

  75. Hermanek P, Sobin LH. TNM Classification of Malignant Tumors. 4th ed. Berlin: Springer-Verlag, 1987.

    Book  Google Scholar 

  76. Stone MJ, Klintmalm GBG, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 104:196–202, 1993.

    PubMed  CAS  Google Scholar 

  77. Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 63:387–94, 1992.

    Article  Google Scholar 

  78. Bismuth H, Chiche L, Adam R, Castaing D. Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation? Transplant Proc 25:1066–7, 1993.

    PubMed  CAS  Google Scholar 

  79. Friedman MA. Chemotherapy for patients with hepatocellular carcinoma: Prospects and possibilities. In Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Houston, TX, Gulf, 1991, pp, 287–292.

    Google Scholar 

  80. Steinherz U, Steinherz PG. Delayed anthracycline cardiac toxicity. Principles Pract Oncol 5:1–15, 1991.

    Google Scholar 

  81. Chemotherapy and hepatitis B (editorial). Lancet 2:1136–7, 1989.

    Google Scholar 

  82. Vogt DP. Current management of cholangiocarcinoma. Oncology 2:37–43, 1988.

    PubMed  CAS  Google Scholar 

  83. Kanematsu T, Furuta T, Takenaka K, et al. A 5-year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10:98–102, 1989.

    Article  PubMed  CAS  Google Scholar 

  84. Venook AP, Stagg RJ, Lewis BJ, et al. Chemoembolization for hepatocellular carcinoma. J Clin Oncol 8:1108–14, 1990.

    PubMed  CAS  Google Scholar 

  85. Yamashita Y, Takahashi M, Koga Y, et al. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 67:385–91, 1991.

    Article  PubMed  CAS  Google Scholar 

  86. Raoul JI, Bretagne JF, Caucanas JP, et al. Internal radiation therapy for hepatocellular carcinoma. Cancer 69:346–52, 1992.

    Article  PubMed  CAS  Google Scholar 

  87. Yu Y, Xu D, Zhou X, et al. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 71:62–5, 1993.

    Article  PubMed  CAS  Google Scholar 

  88. Kanematsu T, Matsumata T, Shirabe K, et al. A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma. Cancer 71:2181–6, 1993.

    Article  PubMed  CAS  Google Scholar 

  89. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 69:925–9, 1992.

    Article  PubMed  CAS  Google Scholar 

  90. Tanaka K, Nakamura S, Numata. K, et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185:457–60, 1992.

    PubMed  CAS  Google Scholar 

  91. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: Results in 146 patients. Am J Roentgenol 160:1023–8, 1993.

    Article  CAS  Google Scholar 

  92. Lai CI, Lau JYN, Wu PC, et al. Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology 17:389–94, 1993.

    Article  PubMed  CAS  Google Scholar 

  93. Farinati F, Salvagnini M, de Maria N, et al. Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol 11:297–301, 1990.

    Article  PubMed  CAS  Google Scholar 

  94. Carlson RI, Ben-Porath E, Shouval D, et al. Antigenic characterization of human hepatocellular carcinoma. J Clin Invest 76:40–51, 1985.

    Article  PubMed  CAS  Google Scholar 

  95. Takahashi H, Ozturk M, Vilson B, et al. In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma. Hepatology 9:625–34, 1989.

    Article  PubMed  CAS  Google Scholar 

  96. Keegan-Rogers V, Wu GY. Immunotargeting in the diagnosis and treatment of liver cancer. Hepatology 9:646–8, 1989.

    Article  PubMed  CAS  Google Scholar 

  97. Bismuth H, Chiche L, Adam R, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218:145–51, 1993.

    Article  PubMed  CAS  Google Scholar 

  98. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–9, 1996.

    Article  PubMed  CAS  Google Scholar 

  99. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434–40, 1999.

    Article  PubMed  CAS  Google Scholar 

  100. Kanematsu T, Takenaka K, Furuta T, et al. Acute portal hypertension associated with liver resection. Analysis of early postoperative death ArchSWg 120:1303–5, 1985.

    CAS  Google Scholar 

  101. Elias D, Debaere T, Roche A, et al. Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver. Hepatogastroenterology 45:170–7, 1998.

    PubMed  CAS  Google Scholar 

  102. Marcos A, Ham JM, Fisher RN, et al. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 6:296–301,2000.

    Article  PubMed  CAS  Google Scholar 

  103. Starzl TE, Iwatsuki S, Shaw BJ, Nalesnik MA, Farhi DC, Van Thiel D. Treatment of fibrolamellär hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 162:145–8, 1986.

    PubMed  CAS  Google Scholar 

  104. Nakajima T, Kondo Y, Miyazald M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma. Hum Pathol 19:1228–34, 1988.

    Article  PubMed  CAS  Google Scholar 

  105. Ma CK, Zarbo RJ, Frierson HF, Lee MW. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 99:551–7, 1993.

    PubMed  CAS  Google Scholar 

  106. Swanson PE. Diagnostic immunohistochemistry. Am J M Pathol 99:530–2, 1993.

    CAS  Google Scholar 

  107. Wanebo HJ, Ahlgren JD, Macdonald JS, eds. Gastrointestinal Oncology. Philadelphia, JB Lippincott 1992, pp399–416

    Google Scholar 

  108. Chen MF, Jan YY, Wang CS, et al. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer 64:2226–32, 1989.

    Article  PubMed  CAS  Google Scholar 

  109. Farrant JM, Hayliar KM, Wilkinson ML, et al Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100:1710–7, 1991.

    PubMed  CAS  Google Scholar 

  110. Calne RY. Liver transplantation for liver cancer. World J Surg 10:76–80, 1986.

    Article  Google Scholar 

  111. Iwatsuki S, Klintmalm GBG, Starzl TE. Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg 6:81–5, 1982.

    Article  PubMed  CAS  Google Scholar 

  112. Neuhaus P, Proelsch C, Ringe B, Pichlmayr R. Liver transplantation for liver tumors. In: Herfarth C, Schlag P, Hohenberger P, eds. Therapeutic Strategy in Primary and Metastatic Liver Cancer. New York: Springer Verlag, 1986:221–8.

    Chapter  Google Scholar 

  113. Weiss JW, Enzinger FM. Epithelioid haemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 50:970–81, 1982.

    Article  PubMed  CAS  Google Scholar 

  114. Forbes A, Portmann B, Johnson P, Williams R. Hepatic sarcomas in adults: a review of 25 cases. Gut 28:668–74, 1987.

    Article  PubMed  CAS  Google Scholar 

  115. Marino IR, Todo S, Tzakis AG, et al. Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 62:2079–84, 1988.

    Article  PubMed  CAS  Google Scholar 

  116. Kelleher MB, Iwatsuld S, Sheahan DG. Epithelioid hemangioendothelioma of liver. Am JSurg Pathol 13:999–1008, 1989.

    Article  CAS  Google Scholar 

  117. Yokoyama I, Carr B, Saitsu HL, et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 68:2095–2100, 1991.

    Article  PubMed  CAS  Google Scholar 

  118. Busuttil R, Klintmalm G, eds. Transplantation of the Liver, Philadelphia, WB Saunders 1996, pp 130–133

    Google Scholar 

  119. Arnold JC, O’Grady JG, Bird GL, Caine RY, Williams R. Liver transplantation for primary and secondary hepatic apudomas. Br J Surg 76:248–9, 1989.

    Article  PubMed  CAS  Google Scholar 

  120. Makowka L, Tzakis AG, Mazzaferro V, et al. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 168:107–11,1989.

    PubMed  CAS  Google Scholar 

  121. Lobe TE, Vera SR, Bowman LC, Fontanesi J, Britt, LG, Gaber AO. Hepaticopancreaticogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood. J Pediatr Surg 27:227–9, 1992.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northwestern University Medical School, Chicago, IL, USA

    Alan Koffron M.D., Jonathan P. Fryer M.D. & Michael Abecassis M.D.

Authors
  1. Alan Koffron M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan P. Fryer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Abecassis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Northwestern University Medical School, Chicago, IL, USA

    Mark S. Talamonti M.D.  & Sam G. Pappas M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Koffron, A., Fryer, J.P., Abecassis, M. (2001). Indications and Results of Liver Transplantation for Primary and Metastatic Liver Cancer. In: Talamonti, M.S., Pappas, S.G. (eds) Liver-Directed Therapy for Primary and Metastatic Liver Tumors. Cancer Treatment and Research, vol 109. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3371-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3371-6_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-3373-0

  • Online ISBN: 978-1-4757-3371-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation